BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for September 3, 2024

Sep. 3, 2024
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Biocon, Janssen, J&J, Regeneron, Regeneron Ireland, Salubris, Yoltech, Zuellig Pharma.
Read More

Other news to note for August 30, 2024

Aug. 30, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Irrimax, Centurion, Pensar, SS Innovations.
Read More

Other news to note for Aug. 30, 2024

Aug. 30, 2024
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biocon Biologics, Biomarin, Janssen, Johnson & Johnson, Repare.
Read More

Other news to note for Aug. 29, 2024

Aug. 29, 2024
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bayer, Flagship Pioneering, Foundation Medicine, Genentech, Merus, Nextrna, Pfizer, Polyrizon, Quotient, Regeneron, Roche, Scisparc, Zuellig.
Read More

Other news to note for August 29, 2024

Aug. 29, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Jupiter, Qiagen.
Read More

Other news to note for Aug. 28, 2024

Aug. 28, 2024

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Addex, Agile, Eli Lilly, Elite, Humacyte, Indivior, Insud, Salubris, Yoltech.


Read More

Other news to note for August 28, 2024

Aug. 28, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biolab, Cerevasc, Glytec, Jedmed, Life Molecular Imaging, Mellingmedical, Roche, Siemens.
Read More

Other news to note for Aug. 28, 2024

Aug. 28, 2024
Additional early-stage research and drug discovery news in brief, from: Cantargia, Mira Pharmaceuticals, Psilera, Transgene.
Read More

Other news to note for Aug. 27, 2024

Aug. 27, 2024
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arca.
Read More

Other news to note for August 27, 2024

Aug. 27, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atricure, Contipi, Eversana, Medtronic, Neuraxis, Pacemate, Sonovascular, Spectral AI.
Read More
Previous 1 2 … 90 91 92 93 94 95 96 97 98 … 1395 1396 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists

    BioWorld Science
    Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
  • Cerebral aneurysm illustration

    Grace Therapeutics hits CRL setback with GTx-104 despite positive trial

    BioWorld
    Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing